Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis

Debapriya Sanyal, Abdullah M. AlShahrani, Soumya Kar, S. Rehan Ahmad, Chittabrata Mal, Sunil Kanti Mondal · 2025

Read Decoding molecular signatures and identifying therapeutic targets in triple-negative breast cancer subtypes using omics and network analysis by Debapriya Sanyal, Abdullah M. AlShahrani, Soumya Kar, S. Rehan Ahmad, Chittabrata Mal, Sunil Kanti Mondal (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12738556.txt.

Description

Triple-negative breast cancer shrugs off hormone and HER2 drugs, leaving chemotherapy as the blunt default. Debapriya Sanyal and co-authors dissect in 2025 its subtypes with multi-omics data, comparing cancer cell lines against normal breast cells to find the transcription factors and marker genes driving each variant. A shared set of cancer-pathway genes surfaced across subtypes.

Judged by mutation patterns, survival links, and expression shifts, eight genes stood out as primary risk factors, including ERBB3, AKT1, and FGFR4. Each ties to particular subtypes, making them candidate markers for tailored treatment. The authors frame the map as a step toward personalized therapy for this stubborn disease.

Catalog record

CREATORDebapriya Sanyal, Abdullah M. AlShahrani, Soumya Kar, S. Rehan Ahmad, Chittabrata Mal, Sunil Kanti Mondal
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE85 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12738556

Browse the full library · About the Tower of Babel